|
PPT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.35831362718864E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67921232474555E-12 |
| Normal-vs-Stage2 |
1.444970E-04 |
| Normal-vs-Stage3 |
1.43210000003169E-06 |
| Normal-vs-Stage4 |
3.404900E-03 |
| Stage1-vs-Stage2 |
5.881000E-01 |
| Stage1-vs-Stage3 |
9.616400E-02 |
| Stage1-vs-Stage4 |
6.718500E-03 |
| Stage2-vs-Stage3 |
5.587800E-01 |
| Stage2-vs-Stage4 |
1.725040E-01 |
| Stage3-vs-Stage4 |
2.871000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.98685512486918E-12 |
| Normal-vs-AfricanAmerican |
2.810100E-02 |
| Normal-vs-Asian |
9.881600E-02 |
| Caucasian-vs-AfricanAmerican |
1.439210E-03 |
| Caucasian-vs-Asian |
8.611000E-01 |
| AfricanAmerican-vs-Asian |
1.579430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22349907982766E-11 |
| Normal-vs-Female |
1.10459996705004E-09 |
| Male-vs-Female |
7.380400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.898100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.5063994496245E-10 |
| Normal-vs-Age(61-80Yrs) |
3.4301006479609E-11 |
| Normal-vs-Age(81-100Yrs) |
1.409990E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.933400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.448000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.917600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.457000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.520600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.594600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.92350000038921E-07 |
| Normal-vs-Grade 2 |
1.62625468647093E-12 |
| Normal-vs-Grade 3 |
4.0251000310576E-09 |
| Normal-vs-Grade 4 |
4.516000E-02 |
| Grade 1-vs-Grade 2 |
4.206000E-01 |
| Grade 1-vs-Grade 3 |
3.927700E-02 |
| Grade 1-vs-Grade 4 |
1.362990E-03 |
| Grade 2-vs-Grade 3 |
1.824260E-02 |
| Grade 2-vs-Grade 4 |
7.92010000000287E-05 |
| Grade 3-vs-Grade 4 |
2.571700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
2.835700E-04 |
| ccA subtype-vs-ccB subtype |
7.71779995467625E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.00059968591404E-11 |
| Normal-vs-N1 |
9.602300E-02 |
| N0-vs-N1 |
8.571600E-01 |
|
|
